Recent OPTH News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/29/2026 05:35:12 PM
- Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia • PR Newswire (US) • 05/29/2026 03:14:00 PM
- Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia • PR Newswire (Canada) • 05/29/2026 03:14:00 PM
- Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia • GlobeNewswire Inc. • 05/29/2026 12:30:00 PM
- Optimi Health Advances Highest-Purity Natural Psilocybin Extract to Date • Newsfile • 05/26/2026 11:00:00 AM
- Optimi Health Announces Closing of Oversubscribed US$15 Million Public Offering • Newsfile • 05/21/2026 05:07:00 PM
- SRx Health Solutions and EMJX Invest in Recent IPO and Commercial-Stage Pharmaceutical Company of Psychedelics, Optimi Health Corp. (OPTH) • GlobeNewswire Inc. • 05/21/2026 01:00:00 PM
- Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting • PR Newswire (US) • 05/20/2026 03:30:00 PM
- Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting • PR Newswire (Canada) • 05/20/2026 03:30:00 PM
- Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting • Newsfile • 05/20/2026 12:00:00 PM
